IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis
Discover Oncology · 29.07.2024 · 15 (1)
DOI: 10.1007/s12672-024-01169-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 29.07.2024. Verfasst von Hong-Xun Ruan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery III, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, Hebei, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science Research Project of the Hebei Provincial Health Commission.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is a prevalent malignancy with high morbidity and mortality rates. Previous studies have demonstrated that interleukin (IL)-22 is involved in CRC progression; however, the exact mechanism remains unclear. This study aimed to investigate the effects of IL-22 on CRC cell proliferation and metastasis.
Methods
IL-22 levels in the serum and tissues of CRC patients were measured using enzyme-linked immunosorbent assay (ELISA). Cell counting kit-8 (CCK-8) assay was used to detect the viability of CRC (HCT116) cells treated with different IL-22 concentrations. Colony formation, Transwell invasion, and scratch assays were employed to assess the effects of IL-22 on cell proliferation, invasion, and migration. Western blotting was performed to measure the expression levels of phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), p-PI3K, p-AKT, E-cadherin, matrix metalloproteinase (MMP)-2, MMP-9, SNAI1, and TWIST1 in HCT116 cells treated with IL-22 or a PI3K inhibitor.
Results
ELISA results showed that the expression of IL-22 was significantly increased in the serum and tissues of CRC patients compared to controls. IL-22 treatment increased cell viability and colony formation in a concentration-dependent manner and enhanced cell invasion and migration. Western blotting analysis revealed that IL-22 stimulation upregulated p-PI3K and p-AKT expression, while total PI3K and AKT levels remained unchanged. Additionally, IL-22 also decreased E-cadherin expression and increased the expression of MMP-2, MMP-9, SNAI1, and TWIST1.
Conclusions
IL-22 activates the PI3K-AKT pathway and promotes HCT116 cell proliferation and metastasis. Targeting the regulation of the PI3K/AKT pathway may be a potential therapeutic strategy for CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery III, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, Hebei, China.
- Department of General Surgery III, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, Hebei, China. Linlin779242000@163.com.
Förderung
- Medical Science Research Project of the Hebei Provincial Health Commission
Zitieren
APA
Ruan, H. X., Qin, X. N., Huang, W., & Lin, L. (2024). IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01169-9
Vancouver
Ruan HX, Qin XN, Huang W, Lin L. IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01169-9
BibTeX
@article{Ruan2024,
author = {Ruan, Hong-Xun and Qin, Xiao-Ning and Huang, Wei and Lin, Lin},
title = {IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01169-9}
}
EUVIMED